E UROpean network of transnational collaborative RTD projects in the field of NANOMEDicine

What are the societal needs? - the challenge for Europe Improve public health and welfare –Ageing population –Efficiency of current medical solutions –Emergence of new disease and old diseases are back –Personalized medicine future directions

The global challenge Therapeutic solutions for only 1/3 known diseases (WHO) Infections: HIV, TB, malaria, risk of pandemia Need to increase capability and innovation of medical industry –Rapid and accurate diagnosis for early detection, even prevention –Novel, more efficient therapies with less side effects

Nano from research to patient and industry Nanomedicine: the application of nanotechnology to achieve breakthroughs in healthcare Foto: kaibara87/

Emerging nanomedicine Lancet Infectious Diseases April issue, vol 9, 2009

Principle of the ERA-net scheme F G UK ES DE CP Without ERA-Net Prog F Prog G Prog UK Prog ES Prog DE Common transnational dedicated CP With ERA-Net … (CP: Call for projects) € : EC supports the coordination costs. Each national programme supports their national partners within the selected projects

EuroNanoMed covers 3/4 of European nanomedicine actors 24 partners from 18 countries/regions Coordination of funding programmes in nanomedicine Started January 2009 for coordination (EU funding for coordination (ERA-net in FP7) 2 common joint calls for proposals 2009, 2010

EuroNanoMed: an asset to bridge the gap 2 calls to support RTD projects aiming at – solving an unmet medical need using nanomedicine – promoting a multidisciplinary translational approach with an international focus EuroNanoMed will achieve a critical mass of actors !!!

EuroNanoMed outputs Develop innovative diagnostic and therapeutic solutions for the patient, enhancing the competitiveness of the European health industry Maturation of the field To bring together –academic teams –clinical/public health teams –industrial research teams Cross-border collaboration between the best researchers/teams in nanomedicine

Why now? What’s the urgency? Health industry: a key for future growth European countries invest substantially in nano industry and basic nano research Nano technologies: a promising field for innovation and patient application Despite these efforts, Europe is lagging behind the US in an increasing competition : Europe needs to act now!

Expected outcome To move innovation from knowledge to industrial technology and health care applications Opening the national programmes to support transnational RTD partnerships Long term vision: formula for an European- wide integrated programme with a coordinated funding

Contacts Coordinator Dr. Pierre-Noël LIRSAC Commissariat à l’Energie Atomique (CEA)  (+33) Network Steering Committee chair Associate Prof. Karin Forsberg-Nilsson Swedish research Council (SRC)

EuroNanoMed ERA Networking towards ERA!

EuroNanoMed First joint transnational call for proposals 18 partners 16 countries/regions

Funding organisations in the first call for proposals Industry, Trade and Tourism Department, Basque Government (ITT), Basque region (Spain) Swiss National Science Foundation (SNSF), Switzerland VDI Technologiezentrum GmbH, Germany Instituto de Salud Carlos III (ISCIII), Spain The French National Research Agency (ANR), France The Chief Scientist Office, The Ministry of Health (CSO-MOH), Israel The Icelandic Centre for Research (RANNIS), Iceland The Latvian Academy of Sciences (LAS), Latvia SenterNovem, The Netherlands National Centre for Research and Development (NCBiR), Poland Fundacao para a Ciencia e a Tecnologia (FCT), Portugal National Center for Programme Management (CNMP), Romania The Swedish Research Council (SRC)(Vetenskapsrådet), Sweden The Swedish Governmental Agency for Innovation Systems (VINNOVA ), Sweden The Scientific and Technological Research Council of Turkey (TUBITAK), Turkey Science Council of Lithuania (LSC), Lithuania Economic development, research and innovation Directorate, Veneto region (Italy) Public Service of Wallonia: Operational General Directorate for Economy, Employment, and Research (DGOEER), Walloon Region (Belgium)

Topics Diagnostics Targeted drug delivery Regenerative medicine

Aim of the 1 st call for proposals To find new medical solutions To enable an effective multi-national collaboration on research projects –Promoting multidisciplinary efforts –Encouraging translational research proposals that combine either basic/clinical and/or industrial approach –Having an added value in funding the transnational collaboration over the individual projects To support novel, ambitious ideas and possibility of application to end users

Eligibility criteria Consortia with room for flexibility –3 -7 partners from at least three partnering countries –At least one clinical/public health research team and/or one industrial research team per consortium –At least two categories (academic/clinical/industrial teams) –Project consortium partners´ eligibility depends upon national regulation

Funding, 1 st call Indicative total funding M€ Funding for up to 3 years Selected projects receive funding directly from their corresponding national/regional funding bodies after meeting their national regulations

Time lines, 1 st call Call opens: End of May 2009 Call closes: September 1 st 2009 Funding decision: December 2009

For more information EuroNanoMed Call office Veneto Nanotech s.c.p.a. Via San Crispino, Padova – Italy  : website: National/regional contacts

Together we're building nanomedicine for the future!